Funding for this research was provided by:
National Key R&D Program of China (2016YFC1303503)
the Key Biomedical Program of Shanghai (17431902200, 18431902600)
Received: 7 December 2018
Accepted: 6 February 2019
First Online: 18 February 2019
Ethics approval and consent to participate
: The study was approved by the Medical Ethics Committee of Fudan University and signed informed consent was obtained from each patient. All animal procedures were approved by the Animal Ethics Committee of Fudan University, experiments were performed in compliance with ARRIVE guidelines.
: All authors consent for publication.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.